Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Sarcoma × anlotinib × Clear all

Phase

Phase 2 8 Phase 1/2 2 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 NSCLC 2 Thyroid Neoplasms 1 Sarcoma 1 Proteinuria 1 Platinum-resistant Ovarian Cancer (PROC) 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

anlotinib 1 Tranexamic Acid 1 Indocyanine Green 1 Enoxaparin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06506838 2024-08-12

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

Guangdong Provincial People's Hospital

Phase 4 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡